October 01, 2012

News from the FDA on bosutinib (Bosulif), ziv-aflibercept (Zaltrap), and everolimus oral suspension tablets (Afinitor Disperz).

Lung cancer awareness is not just for smokers

Nonsmokers can show their support by participating in or creating an awareness event. The editors of Oncology Nurse Advisor offer ways to support lung cancer awareness and to show your support for someone trying to quit.

HF/CM risks in breast chemotherapy

Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.